Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00786721 · ClinicalTrials.gov registry record
Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort
A clinical trial, sponsored by University of California, Irvine.
- Completed
- Registry status
- 9
- Enrollment target
NCT00786721: Completed study, sponsored by University of California, Irvine.
NCT00786721 is a clinical trial that has completed, run by University of California, Irvine. The registered enrollment target is 9 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00786721 has completed, sponsored by University of California, Irvine.
- COMPLETED
- Registry status
- 9 participants
- Enrollment target
Study Summary
There has been increasing support for our hypothesis that mitochondrial dysfunction plays an important role in the etiology of Type 2 Diabetes Mellitus and the overlapping Metabolic Syndrome.
Interventions
- DEVICE Diffuse Optical Spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2006-11 |
| Est. Completion | 2010-08 |
What the finished NCT00786721 record still lists
NCT00786721 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 9 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Diffuse Optical Spectroscopy is the first listed.
NCT00786721 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00786721 about?
NCT00786721 is a clinical study titled "Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort". There has been increasing support for our hypothesis that mitochondrial dysfunction plays an important role in the etiology of Type 2 Diabetes Mellitus and the overlapping Metabolic Syndrome.
What is the current status of trial NCT00786721?
This trial is currently completed. The enrollment target is 9 participants. The study started on 2006-11. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00786721?
The interventions under investigation include: Diffuse Optical Spectroscopy (DEVICE).
Who is sponsoring clinical trial NCT00786721?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia